Items tagged with Vaccines

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy (post with simple image)

UCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases

Large trial will evaluate vaccine’s ability to prevent tuberculosis disease (post with simple image)

Multi-site study underway in Africa

New vaccines targeting adults and teens are best chance to eliminate TB by 2050 (post with simple image)

Targets to eliminate tuberculosis by 2050 are more likely to be met if new vaccines are developed for adults and adolescents instead of for infants.

TB R&D’s shift to the left (post with simple image)

As the Bill & Melinda Gates Foundation realigns its TB vaccine strategy to focus on early-stage candidate development, equitable access priorities must also be established before large-scale trials are conducted.

Researchers participate in the design of a future vaccine for tuberculosis (post with simple image)

Researchers from BIOCAPS will collaborate with scientists from seven countries to design a future vaccine against one of the most persistent diseases worldwide, an infectious disease that provokes one death every 24 seconds: tuberculosis. Specifically, experts from the Institute of Biomedical Research of Vigo (IBI) will search for biomarkers that are correlated with protective immune responses against the pathogen that causes the disease, a key step in the development of an effective vaccine.

4th Global Forum on TB Vaccines convened in Shanghai (post with simple image)

22 May 2015 - Shanghai, China -- Nearly 300 experts in tuberculosis (TB) and TB vaccine development from more than 30 countries around the world gathered in Shanghai in April for the 4th Global Forum on TB Vaccines to discuss the latest efforts and advances in TB vaccine development. The Forum, which was held April 21-24, is convened approximately every other year by the Stop TB Partnership’s Working Group on New Vaccines.

First participant in Impaact P1113 study vaccinated (post with simple image)

Great excitement reigned at the Worcester SATVI Field Site when the first baby participant in the IMPAACT P 1113 Study was vaccinated with the Aeras-404 candidate TB vaccine.

SLU’s vaccine center awarded $2.9 million to study new TB vaccine (post with simple image)

ST. LOUIS -- Saint Louis University's Center for Vaccine Development has received a $2.9 million award from the Bill & Melinda Gates Foundation to study a new tuberculosis vaccine.

HIV i-Base/TAG: 2015 Pipeline Report (post with simple image)

Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

2016 i-Base/TAG Pipeline Report (post with simple image)

Latest annual review on HIV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

Page 8 of 8 · Total posts: 0

←First 7 8